Doximity (DOCS)
(Delayed Data from NYSE)
$28.16 USD
-0.80 (-2.76%)
Updated May 21, 2024 04:00 PM ET
After-Market: $28.16 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DOCS 28.16 -0.80(-2.76%)
Will DOCS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOCS
Company News for May 20, 2024
Doximity (DOCS) Q4 Earnings and Revenues Surpass Estimates
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ahead of Doximity (DOCS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Organon (OGN) Tops Q1 Earnings and Revenue Estimates
Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity
Other News for DOCS
UK earnings, trading statements calendar - next 21 days
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Analysts Offer Insights on Healthcare Companies: Molecular Partners (MOLN), Sagimet Biosciences, Inc. Class A (SGMT) and Doximity (DOCS)
Doximity’s Stock Outperforms with Strong Q4 Results and Positive FY2025 Outlook